Decaudin, Didier
Institut Curie,
France
2025 Rank: 113772
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4317 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113772 | 119072 |
| Total Cites | 8462 | 9652 |
| H-index | 43 | 46 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 116 | 126 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1347 | 1470 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 2216 | 2504 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7522 | 8240 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.17 |
| Self-Citation Percentage |
12.33%
|
|
Decaudin, Didier
Institut Curie,
France
2024 Rank: 110823
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4268 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110823 | 116365 |
| Total Cites | 7976 | 9110 |
| H-index | 42 | 44 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 115 | 125 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1317 | 1439 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 2139 | 2421 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7085 | 7758 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
12.45%
|
|
Decaudin, Didier
Institut Curie,
France
2023 Rank: 108015
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4222 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108015 | 113071 |
| Total Cites | 7553 | 8598 |
| H-index | 39 | 43 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 113 | 123 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1293 | 1410 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 2058 | 2319 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6694 | 7311 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
12.15%
|
|
Decaudin, Didier
Université PSL,
France
2022 Rank: 102553
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4038 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102553 | 108968 |
| Total Cites | 7050 | 8009 |
| H-index | 38 | 40 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 112 | 121 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1254 | 1370 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 1949 | 2200 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6236 | 6796 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
11.97%
|
|
Decaudin, Didier
Institut Curie,
France
2021 Rank: 102112
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4036 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102112 | 106776 |
| Total Cites | 6797 | 7722 |
| H-index | 36 | 39 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 108 | 116 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1229 | 1343 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 1882 | 2124 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6013 | 6546 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
11.98%
|
|
Decaudin, Didier
Institut Curie,
France
2020 Rank: 98074
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4049 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98074 | 103233 |
| Total Cites | 6286 | 7133 |
| H-index | 34 | 37 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 105 | 113 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1189 | 1301 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 1780 | 2012 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5558 | 6039 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
11.87%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.